Attachment 2: Prime Award Terms & Conditions
Special Terms & Conditions
5. Publications: See Att 2a/Standard Terms and Conditions for required acknowledgment and disclaimer. See also Attachment 6, “Open Science.” Abstracts or manuscripts from any CARB–X partner involving CARB–X data must be coordinated with PTE PI at the beginning of the writing process. Subrecipient will provide the PTE with advance copies of all manuscripts related to the Project when they are submitted or re–submitted for publication. PI will have no role in the preparation, editing or approval of the manuscript.
9. Data Rights: Subrecipient grants to PTE the right to use data created in the performance of this Subaward Agreement for the purpose of conducting and publishing anonymized academic research conducted by, or performed in collaboration with, the PTE Principal Investigator and to the extent required to meet PTE’s obligations to the Federal Government under its Prime Award. Per 45 CFR 75.322(d), the Federal Government has the right to: (1) obtain, reproduce, publish, or otherwise use the data produced under a Federal award; and (2) authorize others to receive, reproduce, publish, or otherwise use such data for Federal purposes.
Attachment 6: Research Subaward Agreement
5. Additional Subrecipient Obligations
5.02 Open Science
(a) CARB–X supports the unrestricted access to the published research resulting from the Project and the public dissemination of the results or datasets underpinning any clinical trial or other preclinical or animal–based research, including positive and negative results.
(b) Therefore, the Subrecipient will endeavor to the greatest extent possible, consistent with timely filing of patent applications, to publish results from the Project (whether positive or negative and as described in (a) above), so that the results of this Project are placed in the peer–reviewed literature as soon as practical.
(c) The Subrecipient will make available any publications of research funded by CARB–X through PubMed Central (PMC) and Europe PubMed Central as soon as possible and in any event no later than six months from the date of final publication (in accordance with the Wellcome Trust’s Open Access Policy, and the ASPR Public Access Plan.
(d) The Subrecipient will provide the PTE with advance copies of all manuscripts related to the Project when they are submitted or re–submitted for publication. The PTE will have no role in the preparation, editing or approval of the manuscript. An unpublished patent application will not be deemed to be a manuscript for the purposes of this subsection (d).
Attachment 8: Non Federal Sponsor Terms and Conditions – Gates Foundation
In addition to the requirements detailed in Attachment 2/Special Terms and Conditions #5 and Attachment 6/5.02, if Subrecipient seeks publication in a peer–reviewed journal, such publication shall be under “open access” terms and conditions consistent with the Foundation’s Open Access Policy available at: www.gatesfoundation.org/How–We–Work/General–Information/Open–Access–Policy, which may be modified from time to time. Nothing in this section shall be construed as requiring publication in contravention of any applicable ethical, legal, or regulatory requirements. Subrecipient will mark any such publication subject to this clause with the appropriate notice or attribution, including author, date and copyright (e.g., © 20<> <Name>).